Ophthalmic Drugs Market: Global Size, Trends, Competitive, and Historical

Ophthalmic pharmaceutical markets around the world grow strongly, age -related macular degeneration, diabetic retinopathy, glaucoma and dry eye syndrome at the increasing speed of eye diseases. This development is also complementary to an increasing global geriatric population, number of diabetes cases and increase in exposure of digital screen. Additionally, some development like Anti-VEGF expands the growth market capacity such as sustained-release implants, preservative-free formulations, biologics, biosimilars, and AI-enabled diagnostics are significantly broadening the market's potential.